
Plans for a mass rollout of booster COVID vaccines for the over 50s this autumn may be shelved as the …

NICE has extended its approval of sapropterin (also called Kuvan and made by BioMarin) to pregnant women and people aged …

Europe has approved Evrenzo (roxadustat) for patients with anaemia associated with symptomatic chronic kidney disease. Evrenzo is the first orally …

A face mask has been designed by engineers at MIT and Harvard University that can diagnose the wearer with COVID-19 …

Researchers from Tel Aviv University have used brain cancer patients’ own cells in a form of 3D printing material to …

NICE has launched a public consultation on proposed changes to the way it develops recommendations across its health technology evaluation …

The University of Oxford has begun a Phase I trial using a plague vaccine based on the ChAdOx1 adenovirus viral …

A study led by Oxford University and the Office for National Statistics has found that the AstraZeneca COVID-19 vaccine, though …

Grow Group, a UK medical cannabis firm, announced on Wednesday the acquisition of Sanoid Isolates, a key medical cannabis producer …

The Sackler family, the billionaire owners of Purdue Pharma, vowed in court on Tuesday that unless they are granted legal …

Aspirin is being trialled in combination with immunotherapy drugs as part of a potential new treatment for an aggressive form …

Biotech company IDT has put forward a proposal to the Australian federal government to produce 100 million mRNA vaccines from …

NICE has paused publication of its updated guideline on the diagnosis and management of myalgic encephalomyelitis (or encephalopathy)/chronic fatigue syndrome …

A US federal appeals court has revived nearly 6,000 lawsuits against 3M Co alleging that its widely used device to …

Plasma from blood donations in England will now be used for immunoglobulin treatments in a U-turn in regulation that was …

A report recently published in The Lancet Infectious Diseases journal has found the risk of Bell’s Palsy, a type of …

Novartis has announced positive results from two Phase III clinical trials assessing Beovu in patients with diabetic macular edema. Year …

Biotage has announced the expansion of its production capacity of large-scale flash columns, an element important for the production of …

The number of children in the US who have been hospitalised with COVID-19 has hit a record high. As of …

The UK government has announced that all 16 and 17-year-olds will be offered their first COVID vaccine dose or the …